Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6-Reference-Cited by-同舟云学术

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6

Published:2018-10-17 Issue:11 Volume:13 Page:3131-3141
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

McCoull William¹^ORCID,Cheung Tony²,Anderson Erica²,Barton Peter¹,Burgess Jonathan¹,Byth Kate²,Cao Qing²,Castaldi M. Paola²,Chen Huawei²,Chiarparin Elisabetta¹,Carbajo Rodrigo J.¹,Code Erin²,Cowan Suzanna¹,Davey Paul R.¹,Ferguson Andrew D.²^ORCID,Fillery Shaun¹,Fuller Nathan O.²,Gao Ning²,Hargreaves David¹,Howard Martin R.¹,Hu Jun²,Kawatkar Aarti²,Kemmitt Paul D.¹,Leo Elisabetta¹,Molina Daniel M.³,O’Connell Nichole²,Petteruti Philip²,Rasmusson Timothy²,Raubo Piotr¹,Rawlins Philip B.¹,Ricchiuto Piero¹,Robb Graeme R.¹,Schenone Monica⁴,Waring Michael J.¹,Zinda Michael²,Fawell Stephen²,Wilson David M.¹

Affiliation:

1. Oncology and Discovery Sciences, IMED Biotech Unit, AstraZeneca, 310 Cambridge Science Park, Milton Road, Cambridge CB4 0WG, U.K.

2. Oncology and Discovery Sciences, IMED Biotech Unit, AstraZeneca, Gatehouse Park, Waltham, Massachusetts 02451, United States

3. Pelago Bioscience AB, Banvaktsvägen 20, 17148 Solna, Sweden

4. Broad Institute of Harvard and MIT, 7 Cambridge Center, Cambridge, Massachusetts 02142, United States

Publisher

American Chemical Society (ACS)

Subject

Molecular Medicine,General Medicine,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acschembio.8b00698

Reference40 articles.